Baby Genes, Inc is a Health Care startup founded in 2013. The company is a CAP-Accredited and CLIA-certified diagnostic laboratory offering advanced newborn testing through Next-Generation Sequencing (NGS). Their Newborn Panel tests 100 genes for abnormalities linked to 171 hereditary disorders. This test can be used as a confirmatory/reflex test for kids with abnormal NBS results, as a supplement to state-based newborn screening, or as a family planning/carrier test. With faster and more robust results, Baby Genes enables doctors and parents to take proactive steps to potentially change a newborn's life. There is no publicly known information regarding the last investment or the involved investors.
General Information
Get notified when Baby Genes, Inc moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Baby Genes, Inc
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Health Care
About Baby Genes, Inc
No funding data available for Baby Genes, Inc yet.
Get notified when Baby Genes, Inc raises fundingBaby Genes, Inc Alternatives & Competitors
Pioneering the future of newborn genetic diagnostics with rapid, comprehensive testing for over 500...
The care of your babies and children is our top priority. Overnight Newborn Care and Nanny Placement...
FAQ About Baby Genes, Inc
Don't just browse. Track.
Signal Tracker monitors Baby Genes, Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.